Pharmaceuticals

Global Follicle Stimulating Hormone Industry Trends: Where the Market Is Headed by 2029

November 9, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Follicle Stimulating Hormone Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The follicle stimulating hormone market has observed steady expansion in recent years. It is anticipated to expand from $2.03 billion in 2024 to $2.12 billion in 2025, achieving a compound annual growth rate (CAGR) of 4.4%. The historical growth trajectory can be attributed to the escalating prevalence of hormonal disorders, an increasing need for fertility treatment, the broadening of FSH indications, the introduction of new FSH products to the market, and a rising demand for safe and effective contraceptive options.

The follicle stimulating hormone market is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $2.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include the broadening scope of therapeutic applications, increasing demand for combination therapies, an escalating requirement for effective contraceptive solutions, an aging global population with associated healthcare demands, and market penetration into important geographical areas. Key trends anticipated during this period encompass the development of advanced biosimilar FSH products, obtaining regulatory approvals and facilitating market access, innovations in FSH manufacturing and administration technologies, and the continued emphasis on effective contraceptive methods.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12486&type=smp

What Are The Key Drivers Of Growth In The Follicle Stimulating Hormone Market?

The rising incidence of infertility is anticipated to boost the expansion of the follicle-stimulating hormone market. This condition, defined by a failure to achieve pregnancy after 12 months or more of regular, unprotected intercourse, impacts either the male or female reproductive system. Follicle-stimulating hormone plays a role in fostering egg development within the ovaries and assists in governing the female menstrual cycle. For males, it supports testicular growth and contributes to the production of a vital protein for male fertility by encouraging the formation of healthy sperm. As an illustration, data from April 2023 by the World Health Organization, a Switzerland-based specialized agency of the United Nations, revealed that approximately 1 in 6 adults globally, amounting to about 17.5% of the adult population, suffered from infertility. Additionally, figures from October 2023, provided by the Australian Bureau of Statistics, an Australia-based self-governing constitutional organization tasked with collecting and analyzing data for government recommendations, indicated 300,684 births recorded in 2022, marking a 3% decrease from 2021. The total fertility rate among all Australian women stood at 1.63 births per woman. Consequently, the increasing prevalence of infertility is propelling the expansion of the follicle-stimulating hormone market.

What Are The Key Segments In The Follicle Stimulating Hormone Market?

The follicle stimulating hormone market covered in this report is segmented –

1) By Type: Recombinant FSH, Urinary FSH

2) By Application: Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications

3) By End-Users: Infertility Center, Hospitals, Other End-Users

Subsegments:

1) By Recombinant FSH: Pure Recombinant FSH, Mixed Recombinant FSH Formulations

2) By Urinary FSH: Purified Urinary FSH, Urinary FSH Combined With Other Hormones

What Are The Major Trends Driving The Growth Of The Follicle Stimulating Hormone Market?

Product innovation is a key trend increasing in prominence within the follicle-stimulating hormone market. Major companies active in the follicle-stimulating hormone market are concentrating on creating inventive products to strengthen their standing in the market. As an illustration, in July 2024, Proov, a US-based women’s health company, launched its Proov Empower Perimenopause Testing System. Proov Empower delivers comprehensive and individualized insights into how a woman’s changing hormones impact her overall health and wellness. This non-invasive, multi-time point urine test measures four key hormones—FSH, estrogen marker E1G, progesterone marker PdG, and LH—that influence symptoms and the perimenopause experience. By offering periodic retesting, Proov Empower assists women in monitoring hormone fluctuations and symptoms, thereby acting as a valuable guide throughout the transition to menopause.

Who Are The Major Companies Operating In The Follicle Stimulating Hormone Market?

Major companies operating in the follicle stimulating hormone market include Pfizer Inc., Novartis AG, Abbott Laboratories, Sanofi S.A., Boehringer Ingelheim GmbH, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Cipla Ltd., Ferring Pharmaceuticals Inc., Lupin Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Emcure Pharmaceuticals Ltd., LG Chem’s life sciences, IBSA Group, Bharat Serums and Vaccines Limited, Anhui Anke Biotechnology Group Co. Ltd., Taj Pharmaceuticals Ltd., Genpharm Inc., Cadwell Laboratories Inc., Creative BioMart, Lee Biosolutions Inc., Trumac Healthcare, Midas Pharma GmbH, Biogenix Inc. Pvt. Ltd., Shanghai Techwell Biopharmaceutical Co. Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/follicle-stimulating-hormone-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Follicle Stimulating Hormone Market?

North America was the largest region in the follicle stimulating hormone market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Follicle Stimulating Hormone Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12486&type=smp

Browse Through More Reports Similar to the Global Follicle Stimulating Hormone Market 2025, By The Business Research Company

Hormone Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hormone-therapy-global-market-report

Parathyroid Hormones Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795